These drugs , Semaglutide and Wegovy, represent a significant shift in approaches to treating diabetes and, increasingly, excess weight. They work as GLP-1 mimetics, mimicking the action of a bodily https://marcntiu640977.wikipublicity.com/8826333/copyright_semaglutide_understanding_the_the_glp_1_movement